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The pelvis is the 3rd most common site for surgically treated 
skeletal metastases after the femur and humerus (Ratasvuori 
et al. 2013).
In deciding whether and how to operate on periacetabular 
lesions, the estimated patient survival and size of the skeletal 
lesion should be considered. Expected survival is dependent 
on the type of primary tumor and metastatic burden. The mean 
survival of pathological fractures in the pelvic area is usually 
less than 2 years (Hansen et al. 2004, Ratasvuori et al. 2014).
Periacetabular defects can be reconstructed in several ways 
depending on the extent. Harrington’s classification separates 
cases as follows: class I, the acetabular lateral cortices and 
superior and medial walls are intact; class II, the medial wall is 
deficient; class III, the lateral cortices, medial wall, and supe-
rior wall are all deficient; and class IV, there is wide destruc-
tion all the way to the wing of the ilium (Harrington 1981). 
Harrington also designed a method for reconstruction in cases 
in which the periacetabular bone presents extensive loss, as in 
classes III and IV. In this conventional procedure, antegrade 
pins (from the wing of the ilium to the acetabular dome) or 
retrograde pins (from the acetabular dome into the wing of the 
ilium and into the sacroiliac joint) are used. Other methods are 
also available for the reconstruction, such as filling metastatic 
cavities with bone cement (cementoplasty), acetabular cages, 
custom-made pelvic endoprostheses, and the “ice-cream 
cone” periacetabular prosthesis (Walker 1993, Harrington 
1995, Fisher et al. 2011).
The original Harrington’s procedure is rarely used any more, 
whereas some studies have other procedures, usually less 
invasive, e.g., no pins in the iliac crest (Tsagozis et al. 2015), 
using short screws or pins (Bernthal et al. 2015, Tsagozis et al. 
2015), and not performing arthroplasty (Charles et al. 2017). 
Background and purpose — The pelvis is the 3rd most 
common site of skeletal metastases. In some cases, periace-
tabular lesions require palliative surgical management. We 
investigated functional outcome, complications, and implant 
and patient survival after a modified Harrington’s procedure.
Patients and methods — This retrospective cohort 
study included 89 cases of surgically treated periacetabu-
lar metastases. All patients were treated with the modified 
Harrington’s procedure including a restoration ring. Lesions 
were classified according to Harrington. Functional outcome 
was assessed by Harris Hip Score (HHS) and Oxford Hip 
Score (OHS). Postoperative complications, and implant and 
patient survival are reported.
Results — The overall postoperative functional outcome 
was good to fair (OHS 37 and HHS 76). Sex, age, survival > 
6 and 12 months, and diagnosis of the primary tumor affected 
functional outcome. Overall implant survival was 96% (95% 
Cl 88–100) at 1 year, 2 years, and 5 years; only 1 acetabu-
lar implant required revision. Median patient survival was 8 
months (0–125). 10/89 patients had postoperative complica-
tions: 6 major complications, leading to revision surgery, and 
4 minor complications.
Interpretation — Our modified Harrington’s procedure 
with a restoration ring to achieve stable fixation, constrained 
acetabular cup to prevent dislocation, and antegrade iliac 
screws to prevent cranial protrusion is a reliable reconstruc-
tion for periacetabular metastases and results in a good func-
tional outcome in patients with prolonged survival. A stan-
dardized procedure and low complication rate encourage the 
use of this method for all Harrington class defects.
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Sample sizes in publications reporting conventional and modi-
fied Harrington’s technique are small, ranging from 19 to 51 
patients (Harrington 1981, Nilsson et al. 2000, Tillman et al. 
2008, Shahid et al. 2014, Charles et al. 2017), and the publi-
cations reporting functional outcomes are few (Nilsson et al. 
2000, Charles et al. 2017). 
The aim of this study was to report the functional outcome, 
post-operative implant survival, including complications, and 
patient survival after modified Harrington’s procedure.
Patients and methods
Study design
The medical records from prospectively maintained hospital 
databases were reviewed retrospectively. 89 periacetabular 
metastasis cases treated surgically with the modified Har-
rington’s procedure at Helsinki University Hospital, Helsinki, 
and Coxa Replacement Hospital, Tampere, Finland, were 
included in the analysis. Patients were included if they met the 
following inclusion criteria: age ≥ 18 years, diagnosis of meta-
static disease in the pelvic periacetabular bone, and surgery 
for an impending fracture or existent pathological fracture of 
the periacetabular area between January 2006 and December 
2018 (Table 1). Patients with (multiple) myeloma and lym-
phoma were also included because the surgical approach for 
these diseases is similar to the treatment of metastatic long 
bone disease. No predefined criteria were used by the sur-
geons to make the decision to operate; the patient and physi-
cian together decided whether to operate. 
Preoperative radiological assessment was performed by 
plain radiographs, CT, and/or MRI. Metastatic lesions were 
classified according to Harrington (Harrington 1981).
Surgical procedure
All procedures were performed by orthopedic oncologists, 
and a similar procedure was performed on all patients inde-
pendent of Harrington’s classification. Patients were placed 
under spinal anesthesia, and a preoperative prophylactic anti-
biotic was used. In our modified Harrington’s technique, the 
procedure was started by a posterior approach. The hip was 
dislocated and the neck resected. Curettage of periacetabular 
metastases was performed, and then cannulated mostly fully 
threaded, occasionally partially threaded 7.3 mm screws were 
inserted from the iliac crest through a separate transverse iliac 
incision. The screws were directed to the roof of the acetabu-
lum. The periacetabular defect was then supported by adding 
a Restoration GAP II reinforcement ring (Stryker, Mahwah, 
Table 1. Patient characteristics. Values are number of 






Mean/median follow-up months (range) 18/8 (0–125)
Mean age at surgery years (range) 67 (27–94)
Age
 > 60 62 
 ≤ 60 27
Metastatic load
 Multiple bone 43 
 Solitary bone 18
 Bone, lung, and other 17
 Bone and lung 11
ASA 
 2 14 
 3 41
 4 26




 Pre- and postoperative   2
 None 19
Primary malignant tumor
 Breast  28
 Prostate 13
 Renal cell 11
 Myeloma 10
 Lung   7
 Other 20
Last status
 Dead due to cancer 55
 Dead due to treatment   3
 Dead due to other cause   1
 Dead due to unknown reason 10
 Alive 20
51 year old woman with primary tumor of sigma carcinoma with bone, lung, and 
liver metastasis. Harrington classification 2 (A). The modified Harrington’s proce-
dure for periacetabular metastases (B). 3 cannulated screws are directed to the roof 
of the acetabulum and the periacetabular defect is supported by a restoration rein-
forcement ring. A cemented acetabular cup is implanted. The bone cement is used 
to augment the bone defects, reinforcement ring, and antegrade inserted screws.
   A    B
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NJ, USA). A conventional normal or constrained cemented 
acetabular cup was implanted, followed by the femoral com-
ponent, and bone cement was used to augment the bone 
defects, reinforcement ring, and antegrade inserted screws 
(Figure). Various components were used in both the femur and 
acetabulum throughout the study period (Table 2). Preopera-
tive embolization was selectively performed in 15 cases. The 
majority of patients received postoperative radiation therapy. 
All patients were mobilized postoperatively, allowing imme-
diate full weight-bearing. Postoperative clinical assessment 
was performed routinely after 2–3 months, 6 months, and 12 
months.
Functional outcome
Functional outcome was assessed by the Harris Hip Score 
(HHS) and the Oxford Hip Score (OHS). To report the level of 
the functional outcome, we used the grading system by Mar-
chetti et al. (2005). Functional outcomes based on HHS were: 
< 70, poor; 70–79, fair; 80–89, good; and 90–100, excellent.
The OHS is a patient-reported outcome measure (PROM) 
devised as a joint-specific instrument. A score > 41 is con-
sidered excellent, 34–41 good, 27–33 fair, and < 27 poor 
functional outcome (Kalairajah et al. 2005). To report a good 
functional outcome, we used the definition by Hamilton et al. 
(2018) of “treatment success” for THA patients based on an 
OHS threshold of 37.5 points.
Questionnaires were not used for patients with < 2 months 
of postoperative follow-up or in bad general health, or when 
patients were confined to bed or disoriented by advanced dis-
ease. 
Complications
Minor, major, and mechanical postoperative complications are 
reported. Complications were deemed major when surgical 
reintervention was needed. Mechanical complications were 
defined as an implant failure. Implant survival was defined as 
the time from the Harrington procedure to revision due to any 
cause.
Statistics 
Statistical analyses were performed using SPSS Statistics 23.0 
(IBM Corp, Armonk, NY, USA). A p-value < 0.05 was consid-
ered significant. The Kaplan–Meier method was applied for 
patient and implant survival. Patient survival rates were calcu-
lated from the date of surgery to the most recent follow-up or 
death, and implant survival to revision surgery due to a fail-
ure of the reconstruction. Between-group comparisons were 
performed using the log-rank test. Continuous variables are 
reported as means and 95% confidence intervals (CI). The chi-
squared test or Fisher’s exact test was used to compare vari-
ables between groups, and the Kruskal–Wallis test for means 
between groups. Linear regression analysis was performed to 
determine the relation in scores in a time-series analysis.
Ethics, funding, data sharing plan, and potential con-
flicts of interest
This retrospective cohort study was approved by the local chair 
of the audit department. This research received no specific 
grant or funding from any funding agency in the public, com-
mercial, or not-for-profit sectors. The data are available from 
the corresponding author. No competing interests are declared. 
Results
Functional outcome
Functional outcome data were collected from 53/89 patients. 
The OHS was determined for 18/89 patients and the HHS for 
51/89. Data were missing for 36/89 patients: 14/89 survived 
< 2 months, and 22/89 could not answer the questions due to 
bad general health. Functional outcome measurements were 
performed on average at 1 year (OHS at 17 months and HHS 
at 9 months). 
Table 2. Perioperative characteristics of the 89 patients. 
Values are number of cases unless otherwise specified
Characteristics n
Operation
    Primary only   83
    Revision     6
Mean lesion size (cm) (range)  8.9 (4–25)
Harrington’s classification
    Class I   36
    Class II   41
    Class III   12
    Class IV   –
Preoperative embolization
 Yes   15
 No   69
 Data missing     5
Mean operation blood loss (L) (range)  1.6 (0.1–5.7)
Impending fracture   33
Pathologic fracture   56
Mean operation time (hr) (range) 2.8 (2.2–7.2)
Type of prothesis
 Cemented regular   70
 Uncemented regular     2
 Cemented long-stem     7
 Uncemented long-stem     3
 Tumor prothesis     7
Acetabulum component
 Constrained   56
 Normal   33
Antegrade acetabular pins (n)
 2     3
 3   68
 4   11
 5     7
Head size (mm)
 22     2
 28   11
 30     1
 32   18
 36   57
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The average postoperative OHS was 37 (good), and 6/18 of 
the patients had successful treatment (> 37.5 points) accord-
ing to Hamilton’s definition (Hamilton et al. 2018). The aver-
age HHS was 76, but was statistically significantly better in 
female patients (82 versus 69; p = 0.01), patients aged < 60 
years (87 versus 71; p = 0.001), and in patients with survival > 
6 months (79 versus 67; p = 0.03) and > 12 months (81 versus 
68; p = 0.01). The HHS was better in patients with prostate 
cancer (85; p = 0.04) and worse in patients with myeloma (55; 
p = 0.04) (Table 3). From linear regression analysis, we could 
not detect a statistically significant increase in scores and time.
Implant survival and complications
Overall implant survival was 96% (Cl 88–100) at 1 year, 2 
years, and 5 years. Harrington’s classification (p = 0.9), radio-
therapy (p = 0.3), sex (p = 0.3), and type of primary tumor 
(p = 0.3) did not statistically significantly influence implant 
survival at univariable analysis.
10/89 postoperative complications occurred: 6 major, lead-
ing to revision surgery, and 4 minor, which were treated non-
operatively. 1 patient had mechanical failure of the initial con-
struct due to constant dislocation, necessitating re-intervention 
at 6 months. The postoperative infection rate was 4/89 (Table 
4). We observed fewer dislocations when using constrained 
cups (1/56 patient) when compared with normal cups (3/33 
patients) (p = 0.04). 
Patient survival
55/89 of the patients died of cancer. 3 died due to treatment: 1 
due to fatal pulmonary embolism and 2 due to consequences 
of deep infection and sepsis. Overall patient survival was 46% 
(Cl 35–57) at 1 year, 25% (Cl 14–35) at 2 years, and 16% 
(Cl 7–25) at 5 years. Median patient survival was 8 months 
(0–125). In patients with skeletal and lung metastases, the 
overall survival was 50% at 4 months and 23% at 1 year. 
The survival was significantly better in patients with skeletal 
metastases only, compared with patients with more dissemi-
nated disease (p < 0.001). We could not observe a statistically 
significant difference in survival between patients with soli-
tary or multiple skeletal metastases, nor did we detect a differ-
ence between different Harrington’s classifications on patient 
survival. 
Discussion
We used our modified Harrington technique, namely the inser-
tion of antegrade screws from the iliac crest and an antipro-
trusion cup combined with THA, in all patients with periace-
tabular metastasis and pathological fractures regardless of the 
size of the lesion. Our results show that the reconstruction is 
durable, with low implant-related failure and complication 
rates, and good functional outcomes. 
Functional outcomes have been reported in a few stud-
ies, usually in publications with small sample sizes of Har-
rington or modified Harrington procedure (range 19 to 51 
patients) (Harrington 1992, Nilsson et al. 2000, Tillman et al 
2008, Shahid et al. 2014, Charles et al. 2017), or with non-
specific outcome measures (Tillman et al. 2008, Charles et al 
Table 3. Functional outcome scores
 OHS score HHS score
Characteristics n mean p-value n mean p-value
Eligible cases 18 37  51 76 
Sex   0.6   0.01
 Female 8 38  26 82
 Male 10 36  25 69 
Age over 60 years   0.5   0.001 
 Yes 15 36  36 71
 No 3 41  15 87 
Metastatic load   1.0   1.0
 Multiple bone 10 37  27 76
 Solitary bone 6 37  10 76
 Bone and other 2 37  14 76 
ASA   0.2   0.1
 2 3 46  9 86
 3 5 32  24 74
 4 4 38  12 70 
Radiotherapy   0.5   0.8
 Preoperative 5 34  16 76 
 Postoperative 8 40  27 76
 Pre- and post. 0 –  1 94
 None 5 36  7 73 
Harrington’s classification   0.9   0.3
 Class I 4 36  17 79
 Class II 10 37  24 72
 Class III 4 38  10 80 
Primary malignant tumor    1.0   0.04
 Breast  6 37  19 85
 Prostate 3 40  9 72
 Renal cell 2 33  6 55
 Myeloma 3 35  8 75
 Lung 6 37  19 85
 Other 1 43  4 81 
Survival over 6 months   0.4   0.03
 Yes 16 36  38 79
 No 2 42  13 67 
Survival over 12 months   0.7   0.01
 Yes 15 37  30 81
 No 3 35  21 68 
Operation      0.7
 Primary only 18 37  48 75
 Revision – –  3 80 
Acetabulum component   0.3   0.8
 Constrained 14 36  38 76
 Normal 4 41  13 75 
Table 4. Complications of the Harrington’s procedure cases
Compli- Mechanical Hip joint Local tumor
cations failure dislocation progression Infection Decubitus
Major 1 2 0 2 1
Minor 0 2 1 2 0
Overall 1 4 1 4 1
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2017, Wegrzyn et al. 2018, Rowell et al. 2019). No studies 
have been published using PROMs. Most of the studies have 
used ClinROMs, such as the Musculoskeletal Tumor Society 
(MSTS) score (Harrington 1992, Allan et al. 1995) or the HHS 
(Wegrzyn et al. 2018), which was developed for the assess-
ment of hip surgery outcomes and is intended to evaluate vari-
ous hip disabilities and methods of treatment in an adult popu-
lation. In accordance with the literature, our results shows that 
about half of periacetabular metastasis patients could ambu-
late in the community independently after such large recon-
structive surgery (Wegrzyn et al. 2018, Rowell et al. 2019).
The OHS is a validated, reliable, and well-established PROM 
for evaluating the outcomes of THA (Dawson et al. 1996). It is 
difficult to compare our results with the literature, as postoper-
ative mobility has been reported in different ways (Harrington 
1981, Marco et al. 2000, Shahid et al. 2014, Charles et al. 
2017, Wegrzyn et al. 2018, Rowell et al. 2019). Based on Mar-
chetti’s grading system (Marchetti et al. 2005), the functional 
outcome results were fair in our population when all patients 
were evaluated together (HHS score 76 out of 100). However, 
in young female, mainly breast cancer patients with good esti-
mated survival, the scores were > 80, indicating significantly 
improved results compared with the overall study population. 
The average OHS was 37 in our study. Based on the classi-
fication of Kalairajah et al. (2005), in which a score of 34 to 
41 indicates a good functional outcome, a good outcome is 
represented in our population. In a recent study, Hamilton et 
al. (2018) defined treatment success following THA based on 
an OHS threshold of 37.5 points. In our study, one-third of 
patients had an OHS exceeding this threshold. Again, the best 
OHSs in our study were seen in young female patients with 
long survival. Primary tumor and, most importantly, defect 
defined by Harrington’s classification did not affect the HHS 
or OHS. In accordance with the literature, our results showed 
that age strongly affects functional outcome, as the absolute 
score tends to decrease with age (Bremner-Smith et al. 2004), 
and a patient’s overall physical status is an important factor in 
estimating a good functional outcome. 
Estimating patient survival is of outmost importance, as 
reconstruction survival should be longer than patient survival. 
Since Harrington’s original publication, several modifications 
of the procedure have been introduced, but the idea of trans-
ferring the weight load from the acetabular joint to the intact 
bone in the ileum over the lytic lesion in the periacetabular 
area via threaded screws or pins and a reinforcement ring has 
remained the same. Compared with the literature, our implant 
survival was superior: 96% at 1, 2, and 5 years, as only 1 
reconstruction required revision (Nilsson et al. 2000, Shahid 
et al. 2014, Tsagozis et al. 2015, Erol et al. 2016, Charles et al. 
2017). In the literature, implant survival is rarely reported, but 
reported implant failure rates leading to revision surgery vary 
between 3% and 18%. Revisions are needed due to fractured 
rods, constant or repeated dislocations, and mechanical and 
technical errors similar to our case (Allan et al. 1995, Marco et 
al. 2000, Bernthal et al. 2015, Colman et al. 2015). Complica-
tions after surgery vary considerably, with 11% in our study 
and published reports ranging from 16% to 33% (Nilsson et al. 
2000, Shahid et al. 2014, Tsagozis et al. 2015, Charles et al. 
2017, Krishnan et al. 2017). Complications are often divided 
into major complications requiring surgery and minor compli-
cations, which are treated nonoperatively. Deep infection and 
recurrent dislocation are common major complications requir-
ing revision surgery. Local tumor progression, in addition to 
mechanical instability due to insufficient fixation, is more 
likely to occur in large lesions or long-term survivors (Nilsson 
et al. 2000, Shahid et al. 2014, Tsagozis et al. 2015, Charles 
et al. 2017). In accordance with the literature, dislocation and 
infection were the most common complications in our study, 
and we did not have any failures due to local tumor growth. 
The prognosis of many patients with metastatic bone dis-
ease, particularly those without visceral disease, has improved 
in recent years (Kimura 2018). Although advanced onco-
logical treatment results in the prolonged survival of some 
patients, almost half of the patients die within the 1st year after 
surgery for pelvic metastases. Our patient survival rates are 
in accordance with the literature, with 1-year survival rang-
ing between 42% and 49% (Nilsson et al. 2000, Shahid et al. 
2014, Tsagozis et al. 2015). Visceral metastases decrease sur-
vival, whereas it is suggested that solitary skeletal metastases, 
at least in the extremities, be treated with margins to achieve 
improved survival (Ratasvuori et al. 2014). In our series, the 
skeletal metastasis was solitary in 18 patients, the surgical 
margin was always intralesional, and patient survival was 
similar to patients with more disseminated disease. Increased 
surgical margins in the periacetabular location result in more 
massive resection, with an increased rate of complications; 
therefore, based on our results, we select Harrington’s proce-
dure with intralesional curettage as the method of choice for 
solitary bone metastases in the periacetabular region.
Our study has several limitations, including those inherent 
to its retrospective design. The mobility and functional scores 
were not structurally assessed, and OHS and/or HHS were 
available for only 53/89 of the patients. In addition, 14/89 of 
the patients were deceased before the first follow-up and 22/89 
were unable to come to a follow-up visit. However, the results 
can be used to estimate the probable functional outcome in 
patients with improved survival. A strength of this multi-
center study was the large sample size with a homogeneous 
treatment method for periacetabular metastasis in contrast to 
previous ones, in which very heterogeneous technical methods 
were combined. A further strength of the paper was the use 
of well-validated tools for functional outcome measurement.
In conclusion, functional outcome is mostly dependent on 
patient-related factors, as young female patients with long 
survival have good functional outcomes. The results indicate 
that our modified Harrington’s procedure with the Restoration 
GAP II ring to achieve stable fixation with bone cement, a con-
strained acetabular cup to prevent dislocation, and antegrade 
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iliac screws to prevent cranial protrusion is a reliable recon-
struction for periacetabular metastases and achieves excel-
lent implant survival in all patients. Though the complication 
number was 10/89, the reconstruction survival was surpris-
ingly good, at 96% overall. Furthermore, the overall patient 
survival was 46% at 1 year. Patients with skeletal metastases 
only had improved survival compared with patients with vis-
ceral metastases.
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